Table 2 The 50% and 70% inhibitory concentrations of lenvatinib after 48 h of treatment in bladder cancer cells
Condition | T24 | TSGH | MB49 |
|---|---|---|---|
IC50 | 13.41 µM | 10.65 µM | 12.83 µM |
IC70 | 19.24 µM | 15.68 µM | 18.65 µM |
Condition | T24 | TSGH | MB49 |
|---|---|---|---|
IC50 | 13.41 µM | 10.65 µM | 12.83 µM |
IC70 | 19.24 µM | 15.68 µM | 18.65 µM |